Cetuximab - IRDye800 Intraoperative Fluorescence Imaging in Esophagectomy of Esophageal Cancer
Condition: Drug Safety ; Drug Specificity Intervention: Drug: Cetuximab-IRDye800 Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Erbitux | Esophagectomy | Esophagus Cancer | Hospitals | Research